For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Sex Differences in Statural Growth Impairment in Pediatric Crohn's Disease (Growth Study)

Clinical Trial Details

We are recruiting volunteers (males ages 6 to 15 years and females ages 5 to 13 years) who have Crohn’s disease. We are trying to learn more about growth in pediatric patients with Crohn’s disease with the hope that we may improve the care of pediatric patients with inflammatory bowel disease. Males with pediatric Crohn’s disease more commonly suffer from growth impairment than females.  If we can understand why a sex difference in risk for growth impairment exists, this will be a huge step in our overall understanding of the underlying mechanisms of growth impairment in pediatric Crohn’s disease.

If you are eligible to participate after a screening visit, you will meet with the Growth Study Team five times over two years and do the following:

  • Answer questions about your medical history and physical development
  • Get up to 2 more xrays of your hand to determine your bone age (skeletal maturation)
  • Have your height and weight measured
  • Have blood drawn
  • Record what you eat and drink

OPTIONAL procedures include:

  • Allow a doctor to perform a physical exam to stage your physical development
  • Allow us to store some of your blood for future testing

You will receive a $25 gift as a token of our appreciation for each completed study visit (for a total of a $125 gift over the entire course of the study)

Key Eligibility: 

  • Crohn’s disease
  • Males ages 6 to 15 years
  • Females ages 5 to 13 years
  • Detailed eligibility reviewed when you contact the study team

Growth Study Information Sheet
Growth Study Videos

Follow Dr. Gupta on Twitter @NeeraGuptaMD

Study contact by location

Upper East Side - Manhattan

Contact(s)

Silvia Perez
(646) 962-4968
sip4002@med.cornell.edu

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:

1411015641

Status

Open to Enrollment

Sponsor

Disease